U.S. pharma large copyright scrapped two experimental weight loss supplements past 12 months—a the moment-every day tablet, lotiglipron, because of elevated liver enzymes and also a 2 times-everyday tablet, danuglipron, on account of potent side effects—but CEO Albert Bourla has repo